SWEDISH ORPHAN INTERNATIONAL AB

ORFA

Pharmaceutical preparations for the treatment of rare diseases, namely, in the field of cardiology, diseases affecting immuno compromised patients, genetic disorders, hematology, infectious diseases, metabolic disorders, oncology, pallative care, poison control, respiratory diseases, urology and psychiatric diseases;ORPHAN;The term ORFA has no meaning in a foreign language.;Medical services; medical advice;Medical, biological and chemical research; research and development of new medicines and medical preparations; medical and chemical laboratories;

ORFACOR

Pharmaceutical preparations, namely, pharmaceutical preparations indicated for use in patients with angina pectoris; pharmaceutical preparations for the treatment of cardiac disease;

ORPHAN

The mark consists of a design of a globe with lines and the word ORPHAN in the middle of the globe.;Pharmaceutical preparations for use in the treatment of orphan diseases, namely, diseases related to hematology, genetic disorders, infectious diseases, metabolic disorders, oncology, respiratory diseases, poison control, diseases affecting immunocompromised patients, urology, Tyrosinemia Type I, and kidney stones associated with metabolic etiology; medicines for human use, namely, medicines for the treatment of orphan diseases, namely, diseases related to hematology, genetic disorders, infectious diseases, metabolic disorders, oncology, respiratory diseases, poison control, diseases affecting immunocompromised patients, urology, Tyrosinemia Type I, and kidney stones associated with metabolic etiology; and pharmaceutical preparations and medicine for human use for treatment of pain;ORPHAN;